Buy Keytruda 100 MG in 4 ML Injection at Online

What is Keytruda 100 MG in 4 ML Injection?

Treating certain kinds of melanoma after other medicines have already been tried. keytruda 100 MG in 4 ML Injection is a monoclonal antibody. It works by helping the body’s immune system fight a tumor.

Side Effect

All medicines may cause side effects, but many people have no, or minor keytruda 100 side effects. Check with your doctor if any of these most common side effects persist or become bothersome:

  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • body aches or pain
  • chills
  • constipation
  • cough
  • depressed mood
  • difficulty with breathing
  • difficulty with moving
  • dry skin and hair
  • ear congestion
  • feeling cold
  • fever
  • hair loss
  • headache
  • hoarseness or husky voice
  • loss of voice
  • muscle cramps, pain, and stiffness
  • pain in the joints
  • pale skin
  • rapid weight gain
  • runny or stuffy nose
  • slowed heartbeat
  • sneezing
  • sore throat
  • tingling of the hands or feet
  • trouble breathing
  • troubled breathing with exertion
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • unusual weight gain or loss
  • Chest pain
  • general feeling of discomfort or illness
  • nervousness
  • pain
  • sensitivity to heat
  • stomach cramps
  • sweating
  • Pregnancy

Based on its mechanism of action, pembrolizumab can cause fetal harm when administered to a pregnant woman

Animal data

In animal models, the PD-1/PD-L1 signaling pathway is important in the maintenance of pregnancy through induction of maternal immune tolerance to fetal tissue

Human IgG4 (immunoglobulins) are known to cross the placenta; therefore, keytruda premedication can potentially be transmitted from the mother to the developing fetus

There are no available human data informing the risk of embryo-fetal toxicity

Contraception

Advise females of reproductive potential to use effective contraception during treatment with pembrolizumab fixed dose and for at least 4 months following the final dose

Lactation

Unknown if distributed in human breast milk

No studies have been conducted to assess the impact of keytruda 100mg on milk production or its presence in breast milk Instruct women to discontinue nursing during treatment and for 4 months after the final dose.

Buy Related Medicine :

Buy Jakavi 20mg

Buy Jakavi 5mg Online

Buy Anastronat 1mg

Buy Estramustine 140mg